Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008

Conditions:   Acute Coronary Syndrome;   Stroke Interventions:   Drug: SP-8008 Prototype Capsule A;   Drug: SP-8008 Prototype Capsule B;   Drug: Placebo Sponsor:   Shin Poong Pharmaceutical Co. Ltd. Completed

Source: ClinicalTrials.gov - February 25, 2021 Category: Research Source Type: clinical trials